An FDA-approved synthetic version of THC (the main ingredient in cannabis) reduces agitation in patients with Alzheimer's ...
News Medical on MSN3d
Dronabinol shows promise in reducing agitation in Alzheimer's patientsIn a study led by the Johns Hopkins University School of Medicine and Tufts University School of Medicine, researchers show ...
HealthDay on MSN6d
Synthetic THC may decrease agitation in Alzheimer's patientsA synthetic form of the active ingredient in cannabis helps reduce agitation in people with Alzheimer's, new research shows.
The findings may provide encouragement for the families of the 7 million Americans who have Alzheimer's or another form of dementia. Nine out of 10 develop behavior problems, and agitation is the ...
Related Some diabetes meds might lower risk of dementia ... to treat agitation in people with dementias. "While further analyses are needed to better understand predictors of treatment response ...
Hosted on MSN3d
Dementia treatments: Medication, therapies and lifestyle“These new antibody treatments [lecanemab and donanemab] represent a defining moment in the history of treating Alzheimer’s disease and give much needed hope,” says Katherine Gray, the head of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback